China Galaxy Securities grants "Buy" rating to Beijing Tiantan Biological Products.

Jul 17, 2023 (China Knowledge) - China Galaxy Securities released a research report assigning a "Buy" rating to Beijing Tiantan Biological Products (600161), with a target price range of RMB 29.25-32.50.

The report highlights that Beijing Tiantan Biological Products exceeded expectations in terms of its performance, demonstrating strong growth in Q2 2023 despite facing a high base. This indicates the company's ability to consistently deliver positive results.

The company's efforts in expanding its...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT